Marvel Biosciences Corp.

MRVL.VTSXVHealthcare● Active

$0.20

+$0.01(+2.56%)

Market Cap$12605658

P/E Ratio—

52W High$0.4

52W Low$0.09

Avg Volume61K

Open$0.24

Beta0.59

Earnings Financials Revenue

Marvel Biosciences Corp. (MRVL.V) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MRVL.V · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: Apr 1, 2026

EPS Actual

-$0.01

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

Apr 1, 2026

After Market Close

MRVL.V reports quarterly as a TSXV-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	Jun 17, 2026	—	—	—	—	—	—
— Q2 FY2026	Apr 1, 2026	—	-$0.01	—	—	—	—
— Q4 FY2025	Dec 18, 2025	—	-$0.01	—	—	—	—
— Q3 FY2025	Jul 31, 2025	—	-$0.02	—	—	—	—
— Q2 FY2025	Apr 30, 2025	—	-$0.01	—	—	—	—
— Q1 FY2025	Mar 31, 2025	—	-$0.01	—	—	—	—
— Q4 FY2024	Dec 16, 2024	—	-$0.01	—	—	—	—
— Q3 FY2024	Jul 31, 2024	—	-$0.01	—	—	—	—

Q2 FY2026

Jun 17, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 1, 2026

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2025

Dec 18, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Jul 31, 2025

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

Apr 30, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 31, 2025

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Dec 16, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Jul 31, 2024

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for MRVL.V.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	Apr 1, 2026	—	$0.17	$0.17	-2.94%
— Q4 FY2025	Dec 18, 2025	—	$0.16	$0.15	-3.23%
— Q3 FY2025	Jul 31, 2025	—	$0.17	$0.18	+6.06%
— Q2 FY2025	Apr 30, 2025	—	$0.10	$0.10	+0.00%
— Q1 FY2025	Mar 31, 2025	—	$0.13	$0.13	+4.00%
— Q4 FY2024	Dec 16, 2024	—	$0.15	$0.15	+0.00%
— Q3 FY2024	Jul 31, 2024	—	$0.13	$0.12	-4.00%
— Q2 FY2024	May 10, 2024	—	$0.14	$0.14	-3.57%

Q2 FY2026-2.94%

Report Date

Apr 1, 2026

EPS Beat/Miss

—

Price Before

$0.17

Price After

$0.17

Q4 FY2025-3.23%

Report Date

Dec 18, 2025

EPS Beat/Miss

—

Price Before

$0.16

Price After

$0.15

Q3 FY2025+6.06%

Report Date

Jul 31, 2025

EPS Beat/Miss

—

Price Before

$0.17

Price After

$0.18

Q2 FY2025+0.00%

Report Date

Apr 30, 2025

EPS Beat/Miss

—

Price Before

$0.10

Price After

$0.10

Q1 FY2025+4.00%

Report Date

Mar 31, 2025

EPS Beat/Miss

—

Price Before

$0.13

Price After

$0.13

Q4 FY2024+0.00%

Report Date

Dec 16, 2024

EPS Beat/Miss

—

Price Before

$0.15

Price After

$0.15

Q3 FY2024-4.00%

Report Date

Jul 31, 2024

EPS Beat/Miss

—

Price Before

$0.13

Price After

$0.12

Q2 FY2024-3.57%

Report Date

May 10, 2024

EPS Beat/Miss

—

Price Before

$0.14

Price After

$0.14

Beat Rate0 / 8 quarters

Largest Move+6.06% (Q3 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Marvel Biosciences Corp. (MRVL.V) most recently reported earnings on April 1, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next MRVL.V earnings date is expected around September 1, 2026.

Each quarter, investors track MRVL.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MRVL.V revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

MRVL.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

MRVL.V earnings · 4 questions

Marvel Biosciences Corp.'s next earnings report is expected around September 1, 2026. MRVL.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MRVL.V historically reports after market close (AMC).

MRVL.V earnings datewhen is MRVL.V earningsMRVL.V next earnings datewhen does MRVL.V report earningsMRVL.V earnings calendar

▸ Source: FMP · Marvel Biosciences Corp. SEC filings · US GAAP · Marvel Biosciences Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026